Real-world data shows that roughly 40-50% of requests for branded GLP-1 coverage face initial denial or require step therapy, meaning patients often wait weeks before approval or must absorb out-of-pocket costs upfront
Eryptosis might be ignited and propagated by ROS (ROS-mediated eryptosis), ceramide (lipid-driven eryptosis), Fas signaling (extrinsic eryptosis), and be associated with activation of caspases (caspase-dependent eryptosis)
GLP-1 side effects GLP-1 medications have a different side effect profile, heavily weighted toward gastrointestinal symptoms: Nausea (the most common, affecting 40-50% initially, but typically improving over weeks) Bloating and abdominal discomfort The key difference is trajectory
These combined effects help regulate blood sugar levels and reduce appetite, making it easier to control portions and resist overeating
Pregnant women who dont get enough folate intake put their babies at risk for brain and spinal cord defects